tradingkey.logo

NewGenIvf Group Ltd

NIVF

2.490USD

+0.449+22.00%
Horário de mercado ETCotações atrasadas em 15 min
283.49KValor de mercado
PerdaP/L TTM

NewGenIvf Group Ltd

2.490

+0.449+22.00%
Mais detalhes de NewGenIvf Group Ltd Empresa
NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The Company offers services, such as Mitochondrial Replacement Therapy In Reproductive, Intrauterine Insemination (IUI), Mitochondrial replacement therapy (MRT) techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular / epididymal sperm aspiration or extraction / percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. MRT involves an additional egg from a third person, and manipulating both the recipient egg and the donor egg.
Informações da empresa
Código da empresaNIVF
Nome da EmpresaNewGenIvf Group Ltd
Data de listagemFeb 15, 2022
CEOMr. Claudius Tsang
Número de funcionários76
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 15
EndereçoLevel 39, Marina Bay Financial Centre
Cidade
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísSingapore
Código postal018983
Telefone6568185796
Sitehttps://newgenivf.com/
Código da empresaNIVF
Data de listagemFeb 15, 2022
CEOMr. Claudius Tsang
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Claudius Tsang
Mr. Claudius Tsang
Chairman of the Board, Chief Executive Officer, Chief Financial Officer
Chairman of the Board, Chief Executive Officer, Chief Financial Officer
--
--
Mr. Abuzzal Abusaeri
Mr. Abuzzal Abusaeri
Independent Director
Independent Director
--
--
Mr. John Brebeck
Mr. John Brebeck
Independent Director
Independent Director
--
--
Mr. Giang Nguyen Hoang
Mr. Giang Nguyen Hoang
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Claudius Tsang
Mr. Claudius Tsang
Chairman of the Board, Chief Executive Officer, Chief Financial Officer
Chairman of the Board, Chief Executive Officer, Chief Financial Officer
--
--
Mr. Abuzzal Abusaeri
Mr. Abuzzal Abusaeri
Independent Director
Independent Director
--
--
Mr. John Brebeck
Mr. John Brebeck
Independent Director
Independent Director
--
--
Mr. Giang Nguyen Hoang
Mr. Giang Nguyen Hoang
Independent Director
Independent Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2024
FY2024Q4
FY2024Q3
FY2023
Por EmpresaUSD
Nome
Receita
Proporção
IVF treatment service
5.43M
0.00%
Surrogacy, ancillary caring and other services
0.00
0.00%
Por RegiãoUSD
Nome
Receita
Proporção
Kyrgyzstan
2.66M
48.89%
Thailand
2.18M
40.04%
Cambodia
601.53K
11.07%
HK SAR
0.00
0.00%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
IVF treatment service
5.43M
0.00%
Surrogacy, ancillary caring and other services
0.00
0.00%
Distribuição de ações
Atualizado em: qua, 2 de jul
Atualizado em: qua, 2 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
JAK Opportunities VI LLC
0.80%
Fong (Wai Lam Tina)
0.13%
Siu (Wing Fung Alfred)
0.10%
Chardan Capital Markets, LLC
0.09%
ATW Spac Management LLC
0.06%
Other
98.83%
Investidores
Investidores
Proporção
JAK Opportunities VI LLC
0.80%
Fong (Wai Lam Tina)
0.13%
Siu (Wing Fung Alfred)
0.10%
Chardan Capital Markets, LLC
0.09%
ATW Spac Management LLC
0.06%
Other
98.83%
Tipos de investidores
Investidores
Proporção
Corporation
0.80%
Individual Investor
0.25%
Research Firm
0.12%
Investment Advisor
0.06%
Venture Capital
0.05%
Hedge Fund
0.03%
Other
98.69%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
46
119.76K
1.31%
+103.93K
2025Q1
47
53.83K
2.05%
+29.38K
2024Q4
57
480.38K
3.57%
+160.77K
2024Q3
54
388.28K
4.20%
+63.85K
2024Q2
55
392.14K
4.96%
+40.32K
2024Q1
48
150.75K
80.91%
-221.01K
2023Q4
49
198.33K
101.36%
-231.83K
2023Q3
47
276.28K
99.62%
-143.70K
2023Q2
45
281.16K
89.44%
-138.41K
2023Q1
44
280.74K
89.29%
-146.12K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
JAK Opportunities VI LLC
72.95K
1.7%
+72.95K
--
Apr 20, 2025
Fong (Wai Lam Tina)
11.63K
0.27%
+11.63K
--
Apr 03, 2024
Siu (Wing Fung Alfred)
8.90K
0.21%
+8.90K
--
Apr 03, 2024
Chardan Capital Markets, LLC
7.84K
0.18%
+7.84K
--
Apr 03, 2024
ATW Spac Management LLC
5.63K
0.13%
+5.63K
--
Oct 04, 2024
White Lion Capital LLC
3.50K
0.08%
+3.50K
--
Nov 21, 2024
Sze (Kit Yee)
2.73K
0.06%
+2.73K
--
Apr 03, 2024
Virtu Americas LLC
2.70K
0.06%
+2.70K
--
Mar 31, 2025
Citadel Advisors LLC
2.48K
0.06%
+2.48K
--
Mar 31, 2025
XTX Markets LLC
1.13K
0.03%
+758.00
+205.42%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Jan 31, 2025
Merger
20<1
Jan 31, 2025
Merger
20<1
Jan 31, 2025
Merger
20<1
Jan 31, 2025
Merger
20<1
Data
Tipo
Proporção
Jan 31, 2025
Merger
20<1
Jan 31, 2025
Merger
20<1
Jan 31, 2025
Merger
20<1
Jan 31, 2025
Merger
20<1
KeyAI